Aberdeen Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.06M | Buy |
280,347
+72,288
| +35% | +$2.08M | 0.01% | 644 |
|
|
2025
Q1 | $6.98M | Buy |
208,059
+164,670
| +380% | +$5.52M | 0.01% | 638 |
|
|
2024
Q4 | $2.22M | Buy |
43,389
+7,922
| +22% | +$405K | ﹤0.01% | 753 |
|
|
2024
Q3 | $1.81M | Sell |
35,467
-30,729
| -46% | -$1.57M | ﹤0.01% | 763 |
|
|
2024
Q2 | $2.96M | Sell |
66,196
-35,000
| -35% | -$1.57M | 0.01% | 710 |
|
|
2024
Q1 | $4.74M | Hold |
101,196
| – | – | 0.01% | 675 |
|
|
2023
Q4 | $3.6M | Buy |
+101,196
| New | +$3.6M | 0.01% | 722 |
|